The comparison between CHOP and R-CHOP in primary gastric diffuse large B cell lymphoma

Annals of Hematology

Volumn 91, Issue 11, 2012, Pages 1731-1739

  Sohn, Byeong Seok ^a,b   Kim, Sun Mok ^a   Yoon, Dok Hyun ^a   Kim, Shin ^a   Lee, Dae Ho ^a   Kim, Jin Ho ^a   Lee, Sang Wook ^a   Huh, Jooryung ^a   Suh, Cheolwon ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Inje University College of Medicine   (South Korea)

Author keywords

Primary gastric diffuse large B cell lymphoma; Prognosis; Rituximab . 2 microglobulin

Indexed keywords

BETA 2 MICROGLOBULIN; CD20 ANTIGEN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; KI 67 ANTIGEN; METHYLPREDNISOLONE; PREDNISOLONE; PROTEIN BCL 2; RITUXIMAB; VINCRISTINE;

ADULT; AGE; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DRUG EFFICACY; DRUG MEGADOSE; EVENT FREE SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; STOMACH LYMPHOMA; STOMACH PERFORATION; SURVIVAL RATE; SURVIVAL TIME;

ACADEMIC MEDICAL CENTERS; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BETA 2-MICROGLOBULIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDNISONE; PROGNOSIS; REGISTRIES; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; VINCRISTINE;

EID: 84867333245     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-012-1512-4     Document Type: Article

References (39)

1. Loehr WJ, Mujahed Z, Zahn FD et al (1969) Primary lymphoma of the gastrointestinal tract: a review of 100 cases. Ann Surg 170 (2):232-238
2. Freeman C, Berg JW, Cutler SJ (1972) Occurrence and prognosis of extranodal lymphomas. Cancer 29(1):252-260
3. Koch P, del Valle F, Berdel W et al (2001) Primary gastrointestinal non-Hodgkin's lymphoma: I. Anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German Multicenter Study GIT NHL 01/92. J Clin Oncol 19 (18):3861-3873
4. Papaxoinis G, Papageorgiou S, Rontogianni D et al (2006) Primary gastrointestinal non-Hodgkin's lymphoma: a clinicopathologic study of 128 cases in Greece. A Hellenic Cooperative Oncology Group study (HeCOG). Leuk Lymphoma 47(10):2140-2146
5. D'Amore F, Brincker H, Gronbaek K et al (1994) Non-Hodgkin's lymphoma of the gastrointestinal tract: a population-based analysis of incidence, geographic distribution, clinicopathologic presentation features, and prognosis. Danish Lymphoma Study Group. J Clin Oncol 12(8):1673-1684
6. Paryani S, Hoppe R, Burke J et al (1983) Extralymphatic involvement in diffuse non-Hodgkin's lymphoma. J Clin Oncol 1 (11):682-688
7. Ruskoné-Fourmestraux A, FischbachW, Aleman BMP et al (2011) EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT. Gut 60:747-758
8. Feugier P, Van Hoof A, Sebban C et al (2005) Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol 23:4117-4126
9. Pfreundschuh M, Kuhnt E, Trümper L et al (2011) CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group. Lancet Oncol 12:1013-1022
10. Koch P, Probst A, Berdel W et al (2005) Treatment results in localized primary gastric lymphoma: data of patients registered within the German multicenter study (GIT NHL 02/96). J Clin Oncol 23(28):7050-7059
11. Miller TP, Spier CM, Rimsza L (2006) Diffuse aggressive histologies of non-hodgkin lymphoma. Treatment and biology of limited disease. Semin Hematol 43(4):207-212
12. Armitage JO, How I (2007) treat patients with diffuse large B-cell lymphoma. Blood 110(1):29-36
13. Rabbi C, Aitini E, Cavazzini G et al (1996) Stomach preservation in low-and high-grade primary gastric lymphomas. preliminary results. Haematologica 81(1):15-19
14. Coiffier B, Salles G (1997) Does surgery belong to medical history for gastric lymphomas? Ann Oncol 8(5):419-421
15. Binn M, Ruskoné-Fourmestraux A, Lepage E et al (2003) Surgical resection plus chemotherapy versus chemotherapy alone: comparison of two strategies to treat diffuse large B-cell gastric lymphoma. Ann Oncol 14(12):1751-1757
16. Fischbach W, Dragosics B, Kolve-Goebeler ME et al (2000) Primary gastric B-cell lymphoma: results of a prospective multicenter study. The German-Austrian Gastrointestinal Lymphoma Study Group. Gastroenterol 119:1191-1202
17. Raderer M, Chott A, Drach J et al (2002) Chemotherapy for management of localised high-grade gastric B-cell lymphoma: how much is necessary? Ann Oncol 13:1094-1098
18. Wohrer S, Puspok A, Drach J, Hejna M, Chott A, Raderer M (2004) Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) for treatment of early-stage gastric diffuse large B-cell lymphoma. Ann Oncol 15:1086-1090
19. Aviles A, Castaneda C, Cleto S et al (2009) Rituximab and chemotherapy in primary gastric lymphoma. Cancer Biother Radio 24:25-28
20. Gutiérrez-García G, Colomo L, Villamor N et al (2010) Clinicobiological characterization and outcome of primary nodal and extranodal diffuse large B-cell lymphoma in the rituximab era. Leuk Lymphoma 51:1225-1232
21. Leopardo D, Di Lorenzo G, De Renzo A et al (2010) Efficacy of rituximab in gastric diffuse large B cell lymphoma patients. World J Gastroenterol 16:2526-2530
22. D'Amore F, Christensen BE, Brincker H et al (1991) Clinicopathological features and prognostic factors in extranodal non-Hodgkin lymphomas. Eur J Cancer Clin Oncol 27(10):1201-1208
23. Rohatiner A, on behalf of: D'Amore BC, D. Crowther, M. Gospodarowicz, P. Isaacson, T. A. Lister, A. Norton, P. Salem, M. Shipp, Somers R (1994) Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Ann Oncol 5(5):397-400
24. Cheson BD, Pfistner B, Juweid ME et al (2007) Revised response criteria for malignant lymphoma. J Clin Oncol 25(5):579-586
25. Hans CP, Weisenburger DD, Greiner TC et al (2004) Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 103 (1):275-282
26. Ruskoné-Fourmestraux A, Dragosics B, Morgner A et al (2003) Paris staging system for primary gastrointestinal lymphomas. Gut 52(6):912-913
27. Musshoff K (1977) Clinical staging classification of non-Hodgkin's lymphomas (author's transl). Strahlentherapie 153: 218-221
28. Chihara D, Oki Y, Ine S et al (2010) Primary gastric diffuse large B-cell lymphoma (DLBCL): analyses of prognostic factors and value of pretreatment FDG-PET scan. Eur J Haematol 84(6):493-498
29. Coiffier B, Lepage E, Brière J et al (2002) CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 346(4):235-242
30. Pfreundschuh M, Trümper L, Österborg A et al (2006) CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group. Lancet Oncol 7:379-391
31. Habermann TM, Weller EA, Morrison VA et al (2006) Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma. J Clin Oncol 24:3121-3127
32. Tanaka T, Shimada K, Yamamoto K et al (2011) Retrospective analysis of primary gastric diffuse large B cell lymphoma in the rituximab era: a multicenter study of 95 patients in Japan. Ann Hematol 91(3):383-390
33. Ishikura S, Tobinai K, Ohtsu A et al (2005) Japanese multicenter phase II study of CHOP followed by radiotherapy in stage I-II1, diffuse large B-cell lymphoma of the stomach. Cancer Sci 96:349-352
34. Park YH, Lee S-H, Kim WS et al (2006) CHOP followed by involved field radiotherapy for localized primary gastric diffuse large B-cell lymphoma: results of a multi center phase II study and quality of life evaluation. Leuk lymphoma 47:1253-1259
35. Miller TP, Dahlberg S, Cassady JR et al (1998) Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate-and high-grade non-Hodgkin's lymphoma. N Engl J Med 339:21-26
36. Fischbach W, Schramm S, Goebeler E (2011) Outcome and quality of life favour a conservative treatment of patients with primary gastric lymphoma. Z Gastroenterol 49:430-435
37. Avilés A, Nambo MJ, Neri N, Huerta-Guzmán J et al (2004) The role of surgery in primary gastric lymphoma: results of a controlled clinical trial. Ann Surg 240(1):44-50
38. Bonnet C, Fillet G, Mounier N et al (2007) CHOP alone compared with CHOP plus radiotherapy for localized aggressive lymphoma in elderly patients: a study by the Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol 25:787-792
39. Persky DO, Unger JM, Spier CM et al (2008) Phase II study of rituximab plus three cycles of chop and involved-field radiotherapy for patients with limited-stage aggressive B-cell lymphoma: Southwest Oncology Group Study 0014. J Clin Oncol 26(14):2258-2263